Anticoagulants (blood thinners) on every 2026 Virgin Islands Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in Virgin Islands cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | AARP Medicare Rx Preferred from UHC$114.80/moS5820-038 |
|---|---|
| Eliquisapixaban | Tier 325%QL 60/30d |
| Xareltorivaroxaban | Tier 325%QL 30/30d |
| rivaroxabangeneric Xarelto | Tier 325%QL 360/30d |
| dabigatrangeneric Pradaxa | Tier 425%QL 60/30d |
| Savaysaedoxaban | No 2026 Part D formulary lists this drug in the CMS files: it is too new, no longer sold, or excluded from Part D (as weight-loss-only drugs are). |
| warfaringeneric Coumadin | Tier 125% |
| Jantovenwarfarin | Tier 125% |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.